Measuring the End of Life Premium in Cancer using Individual ex ante Willingness to Pay

Sara Olofsson (), Ulf-G. Gerdtham, Lars Hultkrantz and Ulf Persson ()
Additional contact information
Sara Olofsson : The Swedish Institute for Health Economics (IHE), Postal: Lund, Sweden
Ulf Persson: The Swedish Institute for Health Economics (IHE), Postal: Lund, Sweden

No 2016:23, Working Papers from Lund University, Department of Economics

Abstract: For the assessment of value of new therapies in healthcare, Health Technology Assessment (HTA) agencies often review the cost per Quality-Adjusted Life-Years (QALY) gained. Some HTAs accept a higher cost per QALY gained when treatment is aimed at prolonging survival for patients with a short expected remaining lifetime, a so called End-Of-Life (EoL) premium. The objective of this study is to elicit the existence and size of an EoL premium in cancer. Data was collected from 509 individuals in the Swedish general population 20-80 years old using a web-based questionnaire. Preferences were elicited using subjective risk estimation and the contingent valuation (CV) method. A split-sample design was applied to test for order bias. The value of a QALY at EoL in cancer was between €275,000 and €440,000, which is higher than the thresholds applied by HTAs. When expected remaining life expectancy was 6 months, the value of a QALY was 10-20 % higher compared to when remaining life expectancy was 24 months. Order of scenarios did not have a significant impact on the result and the result showed scale sensitivity. Thus this study supports an EoL premium in cancer when expected remaining lifetime is short.

Keywords: willingness to pay; value of a QALY; cancer; contingent valuation; order bias (search for similar items in EconPapers)
JEL-codes: D61 D80 I18 J17 (search for similar items in EconPapers)
Pages: 34 pages
Date: 2016-09-23
New Economics Papers: this item is included in nep-dcm and nep-hea
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (2)

Downloads: (external link)
https://lucris.lub.lu.se/ws/portalfiles/portal/194594090/WP16_23 Full text (application/pdf)

Related works:
Journal Article: Measuring the end-of-life premium in cancer using individual ex ante willingness to pay (2018)
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hhs:lunewp:2016_023

Access Statistics for this paper

More papers in Working Papers from Lund University, Department of Economics School of Economics and Management, Box 7080, S-22007 Lund, Sweden. Contact information at EDIRC.
Bibliographic data for series maintained by Iker Arregui Alegria ().